Zhu YY - Search Results

1

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.

Feng LH, Zhu YY, Zhou JM, Wang M, Xu WQ, Zhang T, Mao AR, Cong WM, Dong H, Wang L. Feng LH, et al. Among authors: zhu yy. Front Oncol. 2023 May 24;13:1104492. doi: 10.3389/fonc.2023.1104492. eCollection 2023. Front Oncol. 2023. PMID: 37293583 Free PMC article.

2

Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma.

Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W, Liu W, Zhang P, Cong W, Zhu Y, Zhang L, Chen S, Wan D, Zhao X, Huang W, Gu J. Wang G, et al. Genes Chromosomes Cancer. 2001 Jul;31(3):221-7. doi: 10.1002/gcc.1138. Genes Chromosomes Cancer. 2001. PMID: 11391792

3

[The clonal characteristics of late recurrent hepatocellular carcinoma after resection: a study of 2 cases].

Zhu Y, Gu Y, Lu X, Cong W. Zhu Y, et al. Zhonghua Zhong Liu Za Zhi. 2014 Jun;36(6):450-2. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25241788 Chinese. No abstract available.

4

Hepatic carcinosarcoma: evidence of polyclonal origin based on microsatellite analysis.

Gu YJ, Zhu YY, Lu XY, Zhao Q, Cong WM. Gu YJ, et al. Among authors: zhu yy. Pathol Res Pract. 2015 Dec;211(12):905-10. doi: 10.1016/j.prp.2015.09.007. Epub 2015 Sep 8. Pathol Res Pract. 2015. PMID: 26452486

5

An update on primary hepatic solitary fibrous tumor: An examination of the clinical and pathological features of four case studies and a literature review.

Feng LH, Dong H, Zhu YY, Cong WM. Feng LH, et al. Among authors: zhu yy. Pathol Res Pract. 2015 Dec;211(12):911-7. doi: 10.1016/j.prp.2015.09.004. Epub 2015 Sep 10. Pathol Res Pract. 2015. PMID: 26601735 Review.

6

Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.

Feng LH, Dong H, Lau WY, Yu H, Zhu YY, Zhao Y, Lin YX, Chen J, Wu MC, Cong WM. Feng LH, et al. Among authors: zhu yy. J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14. J Cancer Res Clin Oncol. 2017. PMID: 27743138

7

Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.

Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, Chen J; Guideline Committee. Cong WM, et al. Among authors: zhu yy. World J Gastroenterol. 2016 Nov 14;22(42):9279-9287. doi: 10.3748/wjg.v22.i42.9279. World J Gastroenterol. 2016. PMID: 27895416 Free PMC article. Review.

8

The stromal morphological changes for differential diagnosis of uninodular high-grade dysplastic nodule and well-differentiated small hepatocellular carcinoma.

Feng LH, Wang H, Dong H, Zhu YY, Cong WM. Feng LH, et al. Among authors: zhu yy. Oncotarget. 2017 Sep 1;8(50):87329-87339. doi: 10.18632/oncotarget.20607. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152084 Free PMC article.

9

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma.

Dong W, Yu H, Zhu YY, Xian ZH, Chen J, Wang H, Shi CC, Jin GZ, Dong H, Cong WM. Dong W, et al. Among authors: zhu yy. Cancer Manag Res. 2020 Jul 8;12:5537-5547. doi: 10.2147/CMAR.S223417. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753967 Free PMC article.

10

A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis.

Feng LH, Zhu YY, Zhou JM, Wang M, Wang L, Xu WQ, Zhang T, Mao AR, Cong WM, Dong H, Wang L. Feng LH, et al. Among authors: zhu yy. Ann Surg Oncol. 2023 Jan;30(1):363-372. doi: 10.1245/s10434-022-12598-7. Epub 2022 Sep 23. Ann Surg Oncol. 2023. PMID: 36151430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters